These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 8202047

  • 1. Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks.
    Smith MA, Rubinstein L, Ungerleider RS.
    Med Pediatr Oncol; 1994; 23(2):86-98. PubMed ID: 8202047
    [Abstract] [Full Text] [Related]

  • 2. Report of the Cancer Therapy Evaluation Program monitoring plan for secondary acute myeloid leukemia following treatment with epipodophyllotoxins.
    Smith MA, Rubinstein L, Cazenave L, Ungerleider RS, Maurer HM, Heyn R, Khan FM, Gehan E.
    J Natl Cancer Inst; 1993 Apr 07; 85(7):554-8. PubMed ID: 8455202
    [Abstract] [Full Text] [Related]

  • 3. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.
    Pui CH, Ribeiro RC, Hancock ML, Rivera GK, Evans WE, Raimondi SC, Head DR, Behm FG, Mahmoud MH, Sandlund JT.
    N Engl J Med; 1991 Dec 12; 325(24):1682-7. PubMed ID: 1944468
    [Abstract] [Full Text] [Related]

  • 4. Secondary leukemias induced by topoisomerase-targeted drugs.
    Felix CA.
    Biochim Biophys Acta; 1998 Oct 01; 1400(1-3):233-55. PubMed ID: 9748598
    [Abstract] [Full Text] [Related]

  • 5. Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins.
    Smith MA, Rubinstein L, Anderson JR, Arthur D, Catalano PJ, Freidlin B, Heyn R, Khayat A, Krailo M, Land VJ, Miser J, Shuster J, Vena D.
    J Clin Oncol; 1999 Feb 01; 17(2):569-77. PubMed ID: 10080601
    [Abstract] [Full Text] [Related]

  • 6. Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors.
    Kollmannsberger C, Beyer J, Droz JP, Harstrick A, Hartmann JT, Biron P, Fléchon A, Schöffski P, Kuczyk M, Schmoll HJ, Kanz L, Bokemeyer C.
    J Clin Oncol; 1998 Oct 01; 16(10):3386-91. PubMed ID: 9779717
    [Abstract] [Full Text] [Related]

  • 7. Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation.
    Sandoval C, Pui CH, Bowman LC, Heaton D, Hurwitz CA, Raimondi SC, Behm FG, Head DR.
    J Clin Oncol; 1993 Jun 01; 11(6):1039-45. PubMed ID: 8388919
    [Abstract] [Full Text] [Related]

  • 8. High frequency of etoposide (VP-16)-related secondary leukemia in children with non-Hodgkin's lymphoma.
    Sugita K, Furukawa T, Tsuchida M, Okawa Y, Nakazawa S, Akatsuka J, Ohira M, Nishimura K.
    Am J Pediatr Hematol Oncol; 1993 Feb 01; 15(1):99-104. PubMed ID: 8447565
    [Abstract] [Full Text] [Related]

  • 9. Common region of ALL-1 gene disrupted in epipodophyllotoxin-related secondary acute myeloid leukemia.
    Felix CA, Winick NJ, Negrini M, Bowman WP, Croce CM, Lange BJ.
    Cancer Res; 1993 Jul 01; 53(13):2954-6. PubMed ID: 8319201
    [Abstract] [Full Text] [Related]

  • 10. Acute leukemia as a secondary malignancy in children and adolescents: current findings and issues.
    Hijiya N, Ness KK, Ribeiro RC, Hudson MM.
    Cancer; 2009 Jan 01; 115(1):23-35. PubMed ID: 19072983
    [Abstract] [Full Text] [Related]

  • 11. Myelodysplastic syndrome following epipodophyllotoxin therapy in familial hemophagocytic lymphohistiocytosis.
    Henter JI, Elinder G, Lübeck PO, Ost A.
    Pediatr Hematol Oncol; 1993 Jan 01; 10(2):163-8. PubMed ID: 8318372
    [Abstract] [Full Text] [Related]

  • 12. Therapy-related acute myelogenous leukemia associated with 11q23 chromosomal abnormalities and topoisomerase II inhibitors: report of four additional cases and brief commentary.
    Bredeson CN, Barnett MJ, Horsman DE, Dalal BI, Ragaz J, Phillips GL.
    Leuk Lymphoma; 1993 Sep 01; 11(1-2):141-5. PubMed ID: 8220147
    [Abstract] [Full Text] [Related]

  • 13. Implication of prior treatment with drug combinations including inhibitors of topoisomerase II in therapy-related monocytic leukemia with a 9;11 translocation.
    Albain KS, Le Beau MM, Ullirsch R, Schumacher H.
    Genes Chromosomes Cancer; 1990 May 01; 2(1):53-8. PubMed ID: 2177642
    [Abstract] [Full Text] [Related]

  • 14. L-asparaginase may potentiate the leukemogenic effect of the epipodophyllotoxins.
    Pui CH, Relling MV, Behm FG, Hancock ML, Boyett JM, Raimondi SC, Krance RA, Mahmoud HH, Ribeiro RC, Sandlund JT.
    Leukemia; 1995 Oct 01; 9(10):1680-4. PubMed ID: 7564509
    [Abstract] [Full Text] [Related]

  • 15. Two cases of secondary acute myeloid leukemia accompanying adult T-cell leukemia/lymphoma.
    Owatari S, Otsuka M, Uozumi K, Takeshita T, Hanada S.
    Int J Hematol; 2007 Jan 01; 85(1):32-5. PubMed ID: 17261499
    [Abstract] [Full Text] [Related]

  • 16. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.
    Pedersen-Bjergaard J, Philip P, Larsen SO, Andersson M, Daugaard G, Ersbøll J, Hansen SW, Hou-Jensen K, Nielsen D, Sigsgaard TC.
    Leukemia; 1993 Dec 01; 7(12):1975-86. PubMed ID: 8255096
    [Abstract] [Full Text] [Related]

  • 17. Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer.
    Pedersen-Bjergaard J, Sigsgaard TC, Nielsen D, Gjedde SB, Philip P, Hansen M, Larsen SO, Rørth M, Mouridsen H, Dombernowsky P.
    J Clin Oncol; 1992 Sep 01; 10(9):1444-51. PubMed ID: 1517787
    [Abstract] [Full Text] [Related]

  • 18. High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors.
    Kushner BH, Heller G, Cheung NK, Wollner N, Kramer K, Bajorin D, Polyak T, Meyers PA.
    J Clin Oncol; 1998 Sep 01; 16(9):3016-20. PubMed ID: 9738570
    [Abstract] [Full Text] [Related]

  • 19. Epipodophyllotoxin-related acute myeloid leukemia: a study of 35 cases.
    Pui CH, Relling MV, Rivera GK, Hancock ML, Raimondi SC, Heslop HE, Santana VM, Ribeiro RC, Sandlund JT, Mahmoud HH.
    Leukemia; 1995 Dec 01; 9(12):1990-6. PubMed ID: 8609707
    [Abstract] [Full Text] [Related]

  • 20. Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II: from the bedside to the target genes.
    Ratain MJ, Rowley JD.
    Ann Oncol; 1992 Feb 01; 3(2):107-11. PubMed ID: 1318741
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.